Patents by Inventor Kristina Chu

Kristina Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230272491
    Abstract: The present invention relates to compositions comprising and methods of producing genetically engineered bacteriophages, bacteriophage-like particles and non-replicating transduction particles (NRTPs) that contain non-native tail fibers that display altered host specificity and/or reactivity. The present invention also relates to methods of using these bacteriophages and NRTPs for the development of novel diagnostics, therapeutics and/or research reagents for bacteria-related diseases.
    Type: Application
    Filed: January 10, 2023
    Publication date: August 31, 2023
    Inventors: Kyle C. Cady, Colin Lam, Jeffrey Alexander, Kristina Chu, Barbara Eckert, Dylan Goldman, Patrick Lin, Kalyani Mangipudi, Misha Mehta, Arrash Moghaddasi, Hai Nguyen, Natacha Sorenson
  • Patent number: 11572595
    Abstract: The present invention relates to compositions comprising and methods of producing genetically engineered bacteriophages, bacteriophage-like particles and non-replicating transduction particles (NRTPs) that contain non-native tail fibers that display altered host specificity and/or reactivity. The present invention also relates to methods of using these bacteriophages and NRTPs for the development of novel diagnostics, therapeutics and/or research reagents for bacteria-related diseases.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: February 7, 2023
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Kyle C. Cady, Colin Lam, Jeffrey Alexander, Kristina Chu, Barbara Eckert, Dylan Goldman, Patrick Lin, Kalyani Mangipudi, Misha Mehta, Arrash Moghaddasi, Hai Nguyen, Natacha Sorenson
  • Publication number: 20200208226
    Abstract: The present invention relates to compositions comprising and methods of producing genetically engineered bacteriophages, bacteriophage-like particles and non-replicating transduction particles (NRTPs) that contain non-native tail fibers that display altered host specificity and/or reactivity. The present invention also relates to methods of using these bacteriophages and NRTPs for the development of novel diagnostics, therapeutics and/or research reagents for bacteria-related diseases.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 2, 2020
    Inventors: Kyle C. Cady, Colin Lam, Jeffrey Alexander, Kristina Chu, Barbara Eckert, Dylan Goldman, Patrick Lin, Kalyani Mangipudi, Misha Mehta, Arrash Moghaddasi, Hai Nguyen, Natacha Sorenson